Research Article
Dyslipidaemia and Medical Outcome (Health Related Quality of Life) in Patients with Schizophrenia Taking Antipsychotics in Enugu, Nigeria
Table 2
Individual antipsychotics and change in lipid profile.
| Variable | Mean baseline (SD) | Mean end point (SD) | Mean change | -test | df | |
| Haloperidol | | | | | | | TC (mmol/L) | 4.35 (.42) | 4.44 (.43) | 0.09 | 2.172 | 39 | 0.036 | TG (mmol/L) | 1.07 (.25) | 1.25 (.30) | 0.18 | 13.314 | 39 | 0.0001 | HDL (mmol/L) | 1.23 (.12) | 1.15 (.12) | 0.08 | 15.632 | 39 | 0.0001 | LDL (mmol/L) | 2.63 (.37) | 2.72 (.39) | 0.09 | 2.182 | 39 | 0.035 | Chlorpromazine | | | | | | | TC (mmol/L) | 4.30 (.45) | 4.35 (.65) | 0.05 | 0.405 | 4 | 0.706 | TG (mmol/L) | 1.11 (.26) | 1.45 (.05) | 0.34 | 4.687 | 4 | 0.009 | HDL (mmol/L) | 1.34 (.16) | 1.04 (.00) | 0.30 | 7.511 | 4 | 0.002 | LDL (mmol/L) | 2.43 (.37) | 2.57 (.56) | 0.14 | 1.057 | 4 | 0.350 | Trifluoperazine | | | | | | | TC (mmol/L) | 4.14 (.67) | 4.12 (.58) | 0.02 | .300 | 2 | 0.792 | TG (mmol/L) | 1.02 (.31) | 1.25 (.39) | 0.23 | 5.111 | 2 | 0.036 | HDL (mmol/L) | 1.20 (.05) | 1.07 (.04) | 0.13 | 4.298 | 2 | 0.650 | LDL (mmol/L) | 2.46 (.49) | 2.46 (.04) | 0.00 | 0.000 | 2 | 1.000 | Olanzapine | | | | | | | TC (mmol/L) | 4.45 (.26) | 5.01 (.26) | 0.56 | 18.068 | 8 | 0.001 | TG (mmol/L) | 1.00 (.15) | 1.40 (.19) | 0.40 | 18.711 | 8 | 0.001 | HDL (mmol/L) | 1.22 (.04) | 1.04 (.04) | 0.18 | 17.097 | 8 | 0.001 | LDL (mmol/L) | 2.83 (.23) | 3.23 (.39) | 0.40 | 4.724 | 8 | 0.001 | Risperidone | | | | | | | TC (mmol/L) | 4.29 (.39) | 4.49 (.40) | 0.20 | 11.286 | 3 | 0.001 | TG (mmol/L) | .99 (.17) | 1.14 (.22) | 0.15 | 4.469 | 3 | 0.021 | HDL (mmol/L) | 1.16 (.05) | 1.08 (.05) | 0.08 | 0.200 | 3 | 0.008 | LDL (mmol/L) | 2.74 (.39) | 2.87 (.30) | 0.13 | 2.532 | 2 | 0.085 |
|
|
TC = total cholesterol, TG = triglycerides, HDL = high density lipoprotein, LDL = low density lipoproteins, change = change in lipid profile (mmol/L).
|